GlassScriptPhysician profile
Ami A Choi
NPI 1083792311
$3,880.38
in general payments reported to CMS, 2019-2025
19 companies · $1,512 in 2025
The $1,512 reported for 2025 was more than what 87% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $386 · 2022: $149 · 2023: $769 · 2024: $1,064 · 2025: $1,512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,345.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $560.75 | 2022-2024 | Sotyktu |
| Incyte Corporation | $503.36 | 2023-2025 | Opzelura, Opzelura |
| Ucb, INC. | $416.41 | 2023-2025 | Bimzelx |
| Lilly USA, LLC | $412.17 | 2021-2025 | Olumiant, Taltz, Ebglyss |
| Genzyme Corporation | $345.75 | 2024-2025 | |
| Arcutis Biotherapeutics, INC. | $263.69 | 2024-2025 | Zoryve |
| Pfizer INC. | $215.16 | 2021-2025 | |
| Prugen, INC. Pharmaceuticals | $175.00 | 2021 | |
| Organon LLC | $150.00 | 2025 | Vtama |
| Sun Pharmaceutical Industries INC. | $147.86 | 2021-2024 | Ilumya |
| Abbvie INC. | $143.95 | 2021-2025 | |
| Galderma Laboratories, L.P. | $123.09 | 2021-2025 | Nemluvio |
| Dermavant Sciences, INC. | $121.09 | 2023-2024 | Vtama |
| Astrazeneca Pharmaceuticals LP | $111.19 | 2023 | Calquence |
| Amgen INC. | $65.84 | 2024-2025 | Otezla |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Epi Health, LLC | $42.56 | 2021 | |
| Janssen Biotech, INC. | $34.50 | 2025 | Tremfya |
| Leo Pharma INC. | $29.31 | 2025 | Anzupgo |
| Dermira, INC. | $18.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ami Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.